GSK press releases
Follow
ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026
First-in-human data for long-acting formulations of VH184 and early data for capsid inhibitor VH499 to be presented
